Remarkable cytotoxicity against HepG2 cells with high c−MET expression by c−MET−CAR−NK cells in comparison with the lung cancer cell line H1299 that demonstrate low rates of c−MET expression. The gene discussed is MET; the disease is lung carcinoma.